VIDEO: Cendakimab safe, efficacious in treating moderate-to-severe ADJeremy VisserSep 4, 20241 min readAccording to a recent study, cendakimab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in adult patients.
According to a recent study, cendakimab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in adult patients.
Commentaires